title: The Twister laser fiber degradation and tissue ablation capability during 980-nm high-power diode laser ablation of the prostate. A randomized study versus the standard side-firing fiber.
abstract: The objective of this work is to test the ablation capability and fiber degradation of the novel Twister fibers (TW), in both the large (LTW) and the standard (STW) sizes, against the standard side-firing (SF) fiber in a clinical setting during the treatment of BPH patients using the 980-nm high-power diode laser (HPDL). One hundred and twenty BPH patients treated with HPDL (Ceralase300, Biolitec AG, Jena, Germany) were randomized to receive treatment by one of the three fibers. Operative time corrected to tissue volume, laser treatment time, and laser energy were measured. Ablation rate was calculated as follows: the decrease of the prostate volume after 6 months/laser time. The fibers' resistance to degradation was defined by the laser energy needed to degrade the fiber completely. Preoperative prostate volume of 76 ± 38, 70 ± 39, and 88 ± 49 cc decreased by 49 ± 16, 51 ± 20, and 63 ± 16% for the SF, STW, and LTW fibers, respectively. This difference was highly significant when the LTW was compared to the other two fibers (p < 0.001). Prostate volume reduction post-operatively within each group as compared to the pre-operative volume was highly significant (p < 0.001). The ablation rate was highest in LTW, being 1.31 ± 0.59, 1.09 ± 0.51, and 1.54 ± 0.44 cc/min for the SF, STW, and LTW fibers, respectively. The LTW fiber resisted degradation more than the other fibers and the STW more than the SF fiber (p < 0.001). This study demonstrates the higher ablation efficiency and resistance to degradation of the LTW fiber as compared to the STW and SF fibers. The STW fiber has a similar ablation rate of the SF fiber but resists degradation better.
authors.affiliation: Urology Department, Ain Shams University, Cairo, Egypt. hassanshaker@live.com
authors.forename: Hassan
authors.initials: H
authors.lastname: Shaker
authors.forename: Alsayed
authors.initials: A
authors.lastname: Alokda
authors.forename: Hisham
authors.initials: H
authors.lastname: Mahmoud
mesh_terms: D006801:Humans; D053685:Laser Therapy / Q000295:instrumentation* / Q000379:methods; D054023:Lasers, Semiconductor / Q000627:therapeutic use*; D008297:Male; D061646:Operative Time; D009929:Organ Size; D011470:Prostatic Hyperplasia / Q000473:pathology / Q000601:surgery*; D020728:Transurethral Resection of Prostate / Q000295:instrumentation* / Q000379:methods
references.citation: Eur Urol. 2009 Mar;55(3):679-85
references.pmid: 18387731
references.citation: Lasers Med Sci. 2009 Mar;24(2):172-8
references.pmid: 18270761
references.citation: Prostate Cancer Prostatic Dis. 2009;12(3):277-80
references.pmid: 19322136
references.citation: J Endourol. 2010 Nov;24(11):1851-5
references.pmid: 20677991
references.citation: World J Urol. 2007 Jun;25(3):221-5
references.pmid: 17534625
references.citation: Urology. 2010 Mar;75(3):658-63
references.pmid: 20035978
references.citation: J Urol. 2009 Sep;182(3):1078-82
references.pmid: 19616811
references.citation: Surg Laparosc Endosc Percutan Tech. 2007 Jun;17(3):156-63
references.pmid: 17581457
references.citation: Eur Urol. 2007 Dec;52(6):1723-8
references.pmid: 17611013
references.citation: J Endourol. 2004 Apr;18(3):299-302
references.pmid: 15225398
references.citation: Prostate Cancer Prostatic Dis. 2007;10(4):316-22
references.pmid: 17622237